Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Enzastaurin in Metastatic Colorectal Cancer
NCT00192114Phase 2Completed
- Sponsor
- Eli Lilly and Company
- Start
- Aug 2005
- Primary completion
- Mar 2008
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of enzastaurin in colorectal cancer (CRC), sponsored by Eli Lilly and Company. Started Aug 2005; status: completed.
02
Drugs
enzastaurin
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on NCT00192114.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00192114.